Prazosin Alcohol Dependence IVR Study

Completed · Phase 4 · Has a placebo group

Conditions studied: Alcoholism

In brief

This double-blind placebo controlled pilot trial will test the hypothesis that prazosin, an alpha-1 adrenergic receptor antagonist, reduced alcohol consumption and alcohol craving in alcohol dependent individuals without Post Traumatic Stress Disorder (PTSD). The intervention period is six weeks.

Key facts

Study ID

NCT00167687

Run by

University of Washington

People needed

23

Starts

2005-09-01

Expected to finish

2007-10-01

Last updated by the study team

2008-02-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• age 18 years of age or older
• current DSM-IV diagnosis of alcohol dependence with some use in last 30 days
• capacity to provide informed consent
• no planned absences during six week active treatment period that would prevent weekly check-in wiht the study psychiatrist
• English fluency

You may not qualify if…

• Score 50 or greater on the PTSD Check List which suggests a current diagnosis of PTSD
• Psychiatric disorder requiring any medication other than anti-depressants
• Current diagnosis of opiate dependence or abuse, chronic treatment with any opiate-containing medications during the previous month, or urine positive for opioids
• Significant acute or chronic medical illness, including unstable angina, recent myocardial infarction, history of congestive heart failure, preexisting hypotension (systolic lower than 110) or orthostatic hypotension (systolic drop greater than 20mmHg after two minutes standing or any drop with dizziness), insulin-dependent diabetes mellitus; chronic renal or hepatic failure, pancreatitis, gout, Meniere's disease, benign positional vertigo, narcolepsy
• Concomitant use of trazodone, tadalafil or verdenafil
• History of prazosin-sensitivity
• Women who are pregnant, nursing infant(s), or of childbearing potential and not using a contraceptive method judged by the investigator to be effective
• Signs or symptoms of alcohol withdrawal at the time of randomization

Where it is running

• VA Puget Sound Health Care System — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.